Although nasal continuous positive airway influence (CPAP) is effective in the treatment of most numerous patients with obstructive sleep apnea (OSA).

Although nasal continuous positive airway influence (CPAP) is effective in the treatment of most numerous patients with obstructive sleep apnea (OSA), there is a small assemblage of such patients in whom rapid view movement (REM) hypoventilation and [COsub2] retention persist despite the use of CPAP and supplemental oxygen In this report we describe our experience with nocturnal nasal ventilation (nocturnal nasal positive constraining force ventilation [NIPPV] in such patients and its effectiveness in reversing daytime hypercapnia. Thirteen patients, aged 28 to 69 years, with accurate OSA confirmed on polysomnography, failed to be agreeable to to initial CPAP therapy. All were grossly obese (body mass index [BMI] [greater than] 35 kg[multiply by][mlsup-1]) and hypercapnic (mean [PaCO.sub.2], 62 mm Hg) Nocturnal nasal ventilation was commenc using a volume-cycl ventilator, which was well tolerated in all patients. After 7 to 18 days of NIPPV, significant improvements in daytime arterial children gas values were achieved, with a rise in arterial oxygen tension from 50 [+ or -] 26 (SEM) to 66 [+ or -] 3 mm Hg (p [les than] 0001) and a fall in [COsub2] from 62 [+ or -] 25 to 46 [+ or -] 1 mm Hg (p [les than] 00001) Nine of the 13 patients were able to be established forward a regimen of nasal CPAP after this period, while 3 patients required a longer period (up to 3 months) before adequate nocturnal ventilation could be maintained. In the same patient, the improvements in ventilatory drive achieved with NIPPV could not be maintained forward CPAP, and she was transferred in succession to NIPPV long term. These eventuates indicate that effective nasal ventilation leads to an overall improvement in spontaneous ventilation and descendants gas values both awake and asleep. We believe this improvement is the proceed of improved central ventilatory drive. Short-term NIPPV provides lasting benefits allowing the majority of of that kind patients to resume CPAP therapy. Short-term intervention with this therapy should be considered as an interim measure in patients with censorious hypercapnic OSA who fail to be agreeable to to initial CPAP therapy.

The widespread use of nasal continuous positive airway crushing (CPAP) had been a major advance in the treatment of patients with obstructive be still apnea (OSA) and is now generally accepted as the treatment of choice for this condition. Despite cruel oxyhemoglobin desaturation at night, many patients remain eucapnic, with sole a small number exhibiting daytime [COsub2] retention. unruffled in those patients who do cause to grow [CO.sub.2] retention, nasal CPAP has been shown to be an effective treatment modality in the majority of cases.[1] However, in a subgroup of patients with unrelenting OSA and hypercapnia, nasal CPAP may put to the test to be only partially effective despite the reversal of upper airway obstruction. In in the same state [i]or[/i] condition patients, significant desaturation and [COsub2] retention persist, particularly during rapid view movement (REM) sleep, despite high flats of CPAP pressure and the use of supplemental oxygen[2] With careful management and the addition of supplemental oxygen like patients can show slow if it be not that progressive improvement in nocturnal breathing, further this may take weeks or months[3]

Therapeutic options for so patients, in controlling nocturnal respiratory failure and reducing daytime hypercapnia, have in the past been somewhat limited, yet they included such invasive measures as intubation and tracheostomy. However, like approaches in this population attitude particular problems and limitations.[3-5]

In this research we considered the possibility that a more rapid superintend of the sleep-linked respiratory failure could be achieved with nocturnal nasal positive constraining force ventilation (NIPPV), leading to an improved overall flush of ventilatory drive[1,3] and clinical well being thus that nasal CPAP alone would become a more effective long-term therapy. We report herein our experience with NIPPV as a short-term intervention in the treatment of 13 patients with austere OSA and hypercapnia who were refractory to initial CPAP therapy.

METHODS

Thirteen patients with a clinical history indicative of peremptory OSA and daytime hypercapnia quick in emergenciesed to our unit for management. Eleven patients were newly referr for assessment and treatment. The remaining brace patients had been using CPAP for an time (6 and 18 months) and were reassessed because of return of symptoms, including sleepiness, of frequent occurrence nocturnal awakenings, morning headaches, or inability to tolerate their popular CPAP pressure.

All-night doze studies using continuous monitoring of EEG EOG EMG ECG and ear oximetry (Biox 3700e; Boulder Colo) were performed to establish the diagnosis of be dead apnea. Airflow was monitored via nasal cannula attached to a press transducer. Detection of chest wall and abdominal change was made using inductance plethysmography (Respitrace, Ambulatory Monitoring Inc, Ardsley, NY) Data were recorded forward a polygraph (Grass model 8-24E Grass Instruments; Quincy, Mass). In eight patients, continuous transcutaneous [COsub2] measurements were performed. nap stage was classified by the standard criteria of Rechtschaffen and Kales.[6]

...